Wiegand, A.; Friske, M.; Edelmann, S.; Bender, A.; Fischer, L.; Zill, P.; Koller, G.; Bakalkin, G.; Sommer, W.H.; Hansson, A.C.;
et al. Validation of GDAP1 and HECW2 as Epigenetic Markers of Alcohol Use Disorder in Blood and Brain. Int. J. Mol. Sci. 2025, 26, 10840.
https://doi.org/10.3390/ijms262210840
AMA Style
Wiegand A, Friske M, Edelmann S, Bender A, Fischer L, Zill P, Koller G, Bakalkin G, Sommer WH, Hansson AC,
et al. Validation of GDAP1 and HECW2 as Epigenetic Markers of Alcohol Use Disorder in Blood and Brain. International Journal of Molecular Sciences. 2025; 26(22):10840.
https://doi.org/10.3390/ijms262210840
Chicago/Turabian Style
Wiegand, Ariane, Marion Friske, Susanne Edelmann, Annika Bender, Lea Fischer, Peter Zill, Gabriele Koller, Georgy Bakalkin, Wolfgang H. Sommer, Anita C. Hansson,
and et al. 2025. "Validation of GDAP1 and HECW2 as Epigenetic Markers of Alcohol Use Disorder in Blood and Brain" International Journal of Molecular Sciences 26, no. 22: 10840.
https://doi.org/10.3390/ijms262210840
APA Style
Wiegand, A., Friske, M., Edelmann, S., Bender, A., Fischer, L., Zill, P., Koller, G., Bakalkin, G., Sommer, W. H., Hansson, A. C., & Nieratschker, V.
(2025). Validation of GDAP1 and HECW2 as Epigenetic Markers of Alcohol Use Disorder in Blood and Brain. International Journal of Molecular Sciences, 26(22), 10840.
https://doi.org/10.3390/ijms262210840